COVID-19 Vaccine Reactogenicity Marks an Innate Inflammatory Response Associated With HLA Variation and Enhanced Protection

Jill A. Hollenbach(University of California, San Francisco), Stéphanie Gras(La Trobe University), Mark J. Pletcher(Cancer Research And Biostatistics), Corey Smith(QIMR Berghofer Medical Research Institute), Dhilshan Jayasinghe(La Trobe University), Emily Ariens(AGRF Ltd), Irvin Jose(La Trobe University), Joseph J. Sabatino(University of California, San Francisco), Martin Maiers(National Marrow Donor Program), Michael Dewar-Oldis(La Trobe University), Tasneem Yusufali(University of California, San Francisco), Alexis L. Beatty(University of California, San Francisco), Gregory M. Marcus(University of California, San Francisco), Demetra S.M. Chatzileontiadou(La Trobe University), Kleio Ampelakiotou(Evangelismos Hospital), Anurag Adhikari(La Trobe University), Rayo Suseno(University of California, San Francisco), Anshika Srivastava(University of California, San Francisco), Alexandra Tsirogianni(Evangelismos Hospital), Timothy Mercer(AGRF Ltd), Tuong-Khanh My Tu(La Trobe University), Jamie Tuibeo(La Trobe University), Jeffrey Olgin(University of California, San Francisco), Emma Grant(La Trobe University), Andrea Nguyen(La Trobe University), Janesha Maddumage(La Trobe University), Elissavet Kontou(Evangelismos Hospital), Lloyd D’Orsogna(The University of Western Australia), Peter Barnard(La Trobe University), Paul Norman(University of Colorado Anschutz Medical Campus), Ticiana Farias(University of Colorado Anschutz Medical Campus), Katherine Kichula(University of Colorado Anschutz Medical Campus), Samuel Leong(La Trobe University), Thanh Phan(La Trobe University), Noah Peyser(University of California, San Francisco), Juliano Boquett(University of California, San Francisco), Sean Lin(University of California, San Francisco), Katerina Tarassi(Evangelismos Hospital), Dimitrios Zoulas(La Trobe University)
Research Square
June 26, 2026
Cited by 0


Related Papers